VR Logo

Elanco Animal Health Incorporated (ELAN) download report

Healthcare | Drugs & Pharma

Elanco Animal Health Incorporated (ELAN) Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

Please wait...

Please wait...

Please wait...

Please wait...

Please wait...

About The Company

Business: Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals.

IPO Date: 20-Sep-2018

Pres, CEO & Director: Mr. Jeffrey N. Simmons

Exec. VP of Corp. Governance and Strategy & CFO: Mr. Todd S. Young

Listing: NYSE: ELAN

Country: United States

Headquarters: Greenfield, IN

Website: https://www.elanco.com

Key Facts

Market cap: $9,481.92 Mln

Revenue (TTM): $4,748.00 Mln

Earnings (TTM): $-363.00 Mln

Cash: $342.00 Mln

Total Debt: $6,134.00 Mln

Insider's Holding: 4.13%

Liquidity: Low

52 Week range: $19.34 - 37.49

Shares outstanding: 474,096,000

7 Years Aggregate:

  • CFO: $1,489.70 Mln
  • EBITDA: $1,428.60 Mln
  • Net Profit: $-1,447.10 Mln

Stock Performance

Time Period Elanco Animal Health (ELAN) S&P BSE Healthcare S&P Midcap 400
1 month-13.62-3.24-8.89
3 months-20.97-10.55-14.77
1 Year-40.56-15.04-14.84
3 Years-15.1919.035.68
5 Years--8.915.62
10 Years--12.199.32
As on 01-Jul-2022
Year Elanco Animal Health (ELAN) S&P Midcap 400 S&P BSE Healthcare